How a protein affects lung injury caused by silica dust

Regulation of Silica-induced Lung Injury by Plasminogen Activator Inhibitor-1

NIH-funded research University of Texas Hlth Ctr at Tyler · NIH-10370063

This study is looking into how silica dust can harm your lungs and how a protein called PAI-1 might be involved in that damage, with the hope of finding better ways to prevent or treat lung diseases like silicosis for people who work in industries like mining and construction.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Ctr at Tyler NIH-funded
Lab location1 site (Tyler, United States)
Project IDNIH-10370063 on NIH RePORTER

What this research studies

This research investigates the mechanisms behind lung injuries caused by exposure to silica dust, which is common in industries like mining and construction. It focuses on the role of a protein called plasminogen activator inhibitor-1 (PAI-1) and its relationship with inflammatory responses and cell damage in the lungs. By studying these interactions, the research aims to uncover new insights into the development of lung diseases such as silicosis. Patients may benefit from a better understanding of how to prevent or treat these conditions.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals who have been exposed to silica dust in occupational settings, such as miners or construction workers.

Not a fit: Patients with lung diseases not related to silica exposure may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for lung diseases caused by silica exposure.

How similar studies have performed: While there has been research on silica-induced lung injury, the specific focus on the interplay between PAI-1, IL-17A, and autophagy in this context is relatively novel.

Where this research is happening

Tyler, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.